Clinical investigation of lotrafiban has been terminated

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2001年 / 834卷 / 1期

关键词：

Public Health; Clinical Trial; Clinical Efficacy; Medium Release; Clinical Investigation;

D O I：

10.2165/00128415-200108340-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Entacapone has not been associated with liver toxicity in clinical studies
Reactions Weekly, 2000, 829 (1) : 3 - 3
[2] The rimonabant clinical trial programme has been discontinued in all indications
Reactions Weekly, 2008, 1228 (1) : 3 - 3
[3] Development of eptastigmine has been abandoned
Reactions Weekly, 1999, 737 (1) : 3 - 3
[4] The Prescribing Information for Reminyl [galantamine] has been updated
Reactions Weekly, 2005, 1046 (1) : 3 - 3
[5] A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended
Reactions Weekly, 2008, 1212 (1) : 2 - 2
[6] The recent full clinical hold placed on trials of canfosfamide [Telcyta]* has been converted to a partial hold by the US FDA
Reactions Weekly, 2007, 1157 (1) : 3 - 3
[7] The US FDA has been criticised for its handling of the investigation into the contaminated heparin crisis.*
Reactions Weekly, 2010, 1329 (1) : 4 - 4
[8] A generic cyclosporin oral solution [`SangCya'] has been recalled in the US
Reactions Weekly, 2000, 811 (1) : 2 - 2
[9] Topiramate labelling has been revised in the US
Reactions Weekly, 2000, 807 (1) : 4 - 4
[10] Mandatory vaccination has been implemented, and now?
Bizard, F.
MEDECINE ET MALADIES INFECTIEUSES, 2019, 49 (08): : 561 - 562

← 1 2 3 4 5 →